Literature DB >> 26398779

Bone mineral density, microarchitectural and mechanical alterations of osteoporotic rat bone under long-term whole-body vibration therapy.

Pengfei Xie1, Zhurong Tang1, Fangzhu Qing1, Xuening Chen1, Xiangdong Zhu1, Yujiang Fan1, Xiao Yang2, Xingdong Zhang1.   

Abstract

Low-magnitude, high-frequency whole body vibration (WBV) is receiving increasing interest as a non-pharmacological anti-osteoporosis approach. However, the long-term effect of WBV therapy is seldom studied. In this study, the efficacy of 16-week WBV (0.3g, 30 Hz) on bone mineral density (BMD), microarchitectural parameters and mechanical properties of ovariectomized rat femur were examined by in vivo peripheral quantitative computed tomography (pQCT), ex vivo micro-computed tomography (µCT), dynamic mechanical analysis (DMA) and fracture test. To the best of our knowledge, 16 weeks of WBV administration (20 min/day) is currently the longest duration on rodent. The longitudinal BMD change showed that positive effect of WBV on ovariectomized rat femoral neck diminished with prolonged administration duration. In addition, 16-week of WBV treatment was found to cause significantly reduction in the mean BMD, trabecular BMD (Tb.BMD), trabecular bone volume ration (BV/TV), trabecular number (Tb.N) and maximum load in femoral neck of ovariectomized rat. Metaphyseal Tb.BMD and BV/TV were also significantly decreased in WBV treated ovariectomized group than non-treated controls. Whole-femur DMA was demonstrated as a sensitive tool in distinguishing osteoporotic femur from healthy aged-matched controls, in terms of decreased storage modulus (E') and loss factor (tan δ). However, E' and tan δ are not enhanced by 16-week WBV treatment. Together, these findings indicate that administration duration played an important role in the effect of WBV. 16-week WBV may exacerbate trabecular bone loss in ovariectomized rat femur, especially in trabecular-rich femoral neck region. An optimal WBV protocol including administration duration should be established prior to long-term clinical practice.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DMA; Osteoporosis; Viscoelasticity; Whole-body vibration

Mesh:

Year:  2015        PMID: 26398779     DOI: 10.1016/j.jmbbm.2015.08.040

Source DB:  PubMed          Journal:  J Mech Behav Biomed Mater        ISSN: 1878-0180


  6 in total

1.  Multiscale investigation on the effects of additional weight bearing in combination with low-magnitude high-frequency vibration on bone quality of growing female rats.

Authors:  Tianlong Zhang; Jiazi Gao; Juan Fang; He Gong
Journal:  J Bone Miner Metab       Date:  2017-03-14       Impact factor: 2.626

2.  Impact of Whole Body Vibration and Zoledronic Acid on Femoral Structure after Ovariectomy: Morphological Evaluation.

Authors:  Nazar M Kostyshyn; Izabela Świetlicka; Ewa Tomaszewska; Piotr Dobrowolski; Siemowit Muszyński
Journal:  J Clin Med       Date:  2022-04-26       Impact factor: 4.964

3.  Applying vibration in early postmenopausal osteoporosis promotes osteogenic differentiation of bone marrow-derived mesenchymal stem cells and suppresses postmenopausal osteoporosis progression.

Authors:  Huiming Li; Wenchao Wu; Xueling He; Chengjian Cao; Xiaoqin Yu; Ye Zeng; Liang Li
Journal:  Biosci Rep       Date:  2019-09-03       Impact factor: 3.840

4.  Does Low-Magnitude High-Frequency Vibration (LMHFV) Worth for Clinical Trial on Dental Implant? A Systematic Review and Meta-Analysis on Animal Studies.

Authors:  Xinjian Ye; Ying Gu; Yijing Bai; Siqi Xia; Yujia Zhang; Yuwei Lou; Yuchi Zhu; Yuwei Dai; James Kit-Hon Tsoi; Shuhua Wang
Journal:  Front Bioeng Biotechnol       Date:  2021-04-27

Review 5.  Deleterious effects of whole-body vibration on the spine: A review of in vivo, ex vivo, and in vitro models.

Authors:  Folly Patterson; Raheleh Miralami; Keith E Tansey; Raj K Prabhu; Lauren B Priddy
Journal:  Animal Model Exp Med       Date:  2021-03-23

6.  Mineralized collagen-modified PMMA cement enhances bone integration and reduces fibrous encapsulation in the treatment of lumbar degenerative disc disease.

Authors:  Long Yang; Jianjun Kong; Zhiye Qiu; Tieliang Shang; Siyu Chen; Rui Zhao; Maria Grazia Raucci; Xiao Yang; Zhanyong Wu
Journal:  Regen Biomater       Date:  2019-12-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.